Trial
NCT05938608
A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Oxford
Collaborators
Mahidol Oxford Tropical Medicine Research Unit; Mahidol University
Condition
Healthy
Intervention
Regimen 1 (Oral primaquine)
Why stopped
Study team's decision to withdraw the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-06